You have read all your free articles, to continue reading subscribe to read the rest of this content.
The Swedish drug discovery company has announced the completion of its latest financing round, providing funds that will be used to advance its internal pipeline of discovery-stage oncology programmes. The financing round was Beactica’s most successful to date, being almost 60% oversubscribed, Already a subscriber Login You have read all…
NorthX Biologics is expanding into cell therapy manufacturing at its existing GMP-facility, as well as in premises at the Karolinska University Hospital campus in Stockholm. This initiative is part of NorthX's Innovation Hub, an Innovation Track designed to provide development and GMP-manufacturiAlready a subscriber Login You have read all your…
Asarina Pharma, a drug development company focused on the development of a novel therapy for severe premenstrual symptoms, has completed a financing round raising EURO 7 million from new and existing investors for the continued clinical development of Sepranolone. Around 5% of women in fertile agAlready a subscriber Login You…
HiloProbe has attracted new investment capital after developing a diagnostic and prognostic product for colon and rectal cancer. HiloProbe has developed a product called ColoNode that is used for the diagnosis and prognosis of colon and rectal cancer by identifying tumor cells in lymph nodes and Already a subscriber Login…
